Benzinga | May 6, 2021 05:14PM EDT

Recro Pharma Q1 EPS $(0.23) Beats $(0.25) Estimate, Sales $16.80M Beat $16.43M Estimate

Recro Pharma (NASDAQ:REPH) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.25) by 8 percent. This is a 30.3 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $16.80 million which beat the analyst consensus estimate of $16.43 million by 2.25 percent. This is a 22.85 percent decrease over sales of $21.78 million the same period last year.